Ali Khademhosseini

Dr. Khademhosseini is a co-founder of Obsidio, Inc. and the CEO of the Terasaki Institute for Biomedical Innovation. Formerly, he was the Levi Knight Endowed Professor at the University of California-Los Angeles. Dr. Khademhosseini has pioneered the design and development of a variety of hydrogels for regenerative medicine and medical device applications. Khademhosseini’s interdisciplinary research has been recognized by over 40 major national and international awards. He is a recipient of the 2011 Presidential Early Career Award for Scientists and Engineers (PECASE) by President Barack Obama. He has received early career awards from three major engineering discipline societies: electrical (IEEE Engineering in Medicine and Biology award / IEEE Nanotechnology award), chemical (AIChE Colburn award), and mechanical engineering (ASME YC Fung award). In addition, he has received the young investigator awards of the Society for Biomaterials and the Tissue Engineering and Regenerative Medicine International Society-North America. He has also received the American Chemical Society’s Viktor K. Lamer award and the Unilever award and has been recognized by major governmental awards including the NSF Career Award and the Office of Naval Research young investigator award. He has edited multiple books/journal special issues and is an author on >650 peer-reviewed journal articles, editorials and review papers, >70 book chapters/edited books, and >20 patent/disclosure applications. His work has been published in leading journals and routinely highlighted in international media.  He has been cited >73,300 times and has an H-index of 139.

Back to Press